X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (112) 112
humans (110) 110
hematology (103) 103
female (87) 87
male (85) 85
middle aged (85) 85
adult (83) 83
oncology (66) 66
aged (65) 65
adolescent (53) 53
chemotherapy (43) 43
young adult (42) 42
prognosis (40) 40
treatment outcome (38) 38
transplantation (37) 37
acute myeloid leukemia (33) 33
hematology, oncology and palliative medicine (33) 33
risk factors (33) 33
leukemia (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
cancer (27) 27
aged, 80 and over (26) 26
retrospective studies (24) 24
therapy (24) 24
adults (23) 23
medicine & public health (23) 23
stem-cell transplantation (23) 23
stem cells (22) 22
leukemia, myeloid, acute - drug therapy (21) 21
leukemia, promyelocytic, acute - drug therapy (21) 21
recurrence (21) 21
disease-free survival (19) 19
survival (19) 19
acute myelogenous leukemia (18) 18
analysis (17) 17
immunology (17) 17
trans-retinoic acid (17) 17
remission induction (16) 16
risk-adapted treatment (16) 16
acute myeloid-leukemia (15) 15
survival analysis (15) 15
abridged index medicus (14) 14
acute promyelocytic leukemia (14) 14
consolidation (14) 14
cytarabine (14) 14
leukemia, myeloid, acute - genetics (14) 14
leukemia, myeloid, acute - mortality (14) 14
mortality (14) 14
anthracyclines (13) 13
incidence (13) 13
minimal residual disease (13) 13
outcomes (13) 13
remission (13) 13
research (13) 13
survival rate (13) 13
antineoplastic agents - therapeutic use (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
care and treatment (12) 12
diagnosis (12) 12
follow-up studies (12) 12
hematopoietic stem cells (12) 12
mutation (12) 12
tretinoin - administration & dosage (12) 12
anthracycline (11) 11
children (11) 11
competing risk (11) 11
multicenter (11) 11
patients (11) 11
acute lymphoblastic leukemia (10) 10
aml (10) 10
arsenic trioxide (10) 10
cohort studies (10) 10
cytarabine - administration & dosage (10) 10
health aspects (10) 10
hemic and lymphatic diseases (10) 10
idarubicin (10) 10
leukemia, myeloid, acute - diagnosis (10) 10
medical prognosis (10) 10
relapse (10) 10
trial (10) 10
genes (9) 9
genetic aspects (9) 9
precursor cell lymphoblastic leukemia-lymphoma - genetics (9) 9
recommendations (9) 9
acute lymphatic leukemia (8) 8
acute lymphocytic leukemia (8) 8
anthracycline monochemotherapy (8) 8
bone-marrow (8) 8
cord blood stem cell transplantation - methods (8) 8
idarubicin - administration & dosage (8) 8
impact (8) 8
philadelphia chromosome (8) 8
precursor cell lymphoblastic leukemia-lymphoma - mortality (8) 8
prognostic factors (8) 8
recipients (8) 8
risk (8) 8
stem cell transplantation (8) 8
transplantation, homologous (8) 8
tretinoin - therapeutic use (8) 8
unrelated donors (8) 8
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 06/2019, Volume 138, pp. 6 - 13
Secondary AML (sAML), referring to AML arising after prior cytotoxic/radiation/immunosuppressive therapy (tAML) or an antecedent hematologic disorder, now... 
Secondary AML | Therapy | Diagnosis | Therapy-related AML | AML-MRC | AML | DE-NOVO | GEMTUZUMAB OZOGAMICIN | OLDER-ADULTS | THERAPY-RELATED MYELODYSPLASIA | TP53 MUTATIONS | FLT3 MUTATIONS | WORLD-HEALTH-ORGANIZATION | MYELODYSPLASIA-RELATED CHANGES | ONCOLOGY | PROGNOSTIC-SIGNIFICANCE | HEMATOLOGY | Chemotherapy | Anthracyclines | Aged | Immunotherapy | Radiation | Cancer
Journal Article
Leukemia, ISSN 0887-6924, 02/2019, Volume 33, Issue 2, pp. 379 - 389
Journal Article
Mediterranean journal of hematology and infectious diseases, ISSN 2035-3006, 2011, Volume 3, Issue 1, pp. e2011059 - e2011059
Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is the main life-threatening complication of therapy with differentiating agents... 
Differentiation Syndrome, ATRA, Tetinoic Acid | Leukemia, Acute Promyelocytic Leukemia
Journal Article
Annals of Hematology, ISSN 0939-5555, 11/2019, Volume 98, Issue 11, pp. 2467 - 2483
A significant proportion of adult patients with acute myeloid leukemia (AML) fail to achieve complete remission or will relapse later on after achieving it.... 
Refractory | Targeted therapies | Treatment | Medicine & Public Health | Hematology | Relapsed | Oncology | Acute myeloid leukemia
Journal Article
Annals of Hematology, ISSN 0939-5555, 7/2018, Volume 97, Issue 7, pp. 1115 - 1153
Journal Article
The Lancet Oncology, ISSN 1470-2045, 07/2019, Volume 20, Issue 7, pp. 984 - 997
Patients with relapsed or refractory internal tandem duplication ( -ITD)-positive acute myeloid leukaemia have a poor prognosis, including high frequency of... 
AML | DIAGNOSIS | PLUS CYTARABINE | IMPACT | ONCOLOGY | RECOMMENDATIONS | KINASE | TANDEM DUPLICATION | MUTATIONS | OUTCOMES | STEM-CELL TRANSPLANTATION | Chemotherapy | Cancer
Journal Article
International Transactions on Electrical Energy Systems, ISSN 2050-7038, 10/2013, Volume 23, Issue 7, pp. 1095 - 1106
SUMMARY Phase‐locked loop schemes are widely used in induction heating applications for controlling the converters. Most authors use total or partial analog... 
digital | DSP | PLL | resonant converters | induction heating | ENGINEERING, ELECTRICAL & ELECTRONIC | Circuits integrats lineals | Energia elèctrica | Linear integrated circuits | Electrònica de potència | Energies | Àrees temàtiques de la UPC | Enginyeria electrònica
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2019, Volume 381, Issue 18, pp. 1728 - 1740
Oral use of the selective FLT3 kinase inhibitor gilteritinib in patients who had relapsed or refractory acute myeloid leukemia with FLT3 mutations led to a... 
Journal Article
Cancer, ISSN 0008-543X, 08/2019, Volume 125, Issue 16, pp. 2810 - 2817
Journal Article